GSK3B and gastric cancer: In this study, we found that miR-183-96-182 cluster inhibitors decrease the proliferation and migration of gastric cancer AGS cells and provide a functional link between GSK3β, the miRNA-183-96-182 cluster and the β-Catenin/TCF/LEF-1 pathway in gastric cancer.